In short
One appointment that ends with a cause, a cardiac risk category, and a prescription only if it is safe to give one.
- History. Sudden or gradual onset, morning erections, whether desire changed too. This identifies the cause in about 95 percent of cases.
- Bloods. Glucose, lipids, thyroid, blood count, liver and kidney function, and testosterone.
- Cardiac risk graded low, intermediate or high. Sex is exertion, and these medicines cannot be combined with nitrates.
Nobody leaves with a prescription before the heart question has been settled. In Dubai that matters more than usual, because these tablets are widely bought without one.
Treatment Overview
Why so much weight on the history?
Because it is that good. History and examination identify the cause of erectile dysfunction in roughly 95 percent of cases, with far lower specificity, which is exactly why tests follow rather than lead.
Three questions do most of the work. The table gives each one and what the answer tells you.
| Question | What the answer means |
|---|---|
| How did it start? | Sudden onset in a previously unaffected man points to a psychological cause, apart from after pelvic surgery or trauma. Gradual onset points to a physical one |
| Do you still wake with erections? | Their presence shows the nerves and blood flow are intact and points away from a vascular cause |
| Has desire changed too? | Low desire and erectile difficulty are separate problems with different causes and different treatments |
Low desire is treated by finding its cause, because almost every cause has a specific treatment of its own. Treatment by cause.
What is examined?
- Femoral and peripheral pulses, as a clue to vascular disease, and femoral bruits if the pulses are normal
- Penile plaques, which indicate Peyronie disease
- Body and facial hair, breast tissue and testicular size, which point to a hormonal cause
- The cremasteric reflex, as an index of the nerve pathway
- Visual fields, since a pituitary tumour can present this way
Which blood tests, and why?
Fasting glucose or HbA1c, full blood count, liver and kidney function, thyroid function, a lipid profile and total testosterone.
Glucose is not a formality. In men with diabetes attending a community clinic, the prevalence of erectile dysfunction rose from 6 percent at ages 20 to 24 to 52 percent at ages 55 to 59, and in a large survey most men with both had never been asked about it by a doctor.
If testosterone is low, it is repeated with LH and prolactin before any decision is made. How low testosterone is diagnosed.
Why the cardiac question comes before the prescription
Two reasons. Sexual activity is physical exertion, and PDE5 inhibitors are absolutely contraindicated with nitrates in any form, because the combination can cause a severe fall in blood pressure.
There is a third reason, which is about you rather than the drug. Erectile dysfunction is an early warning sign of cardiovascular disease. In an umbrella review of five meta-analyses and two systematic reviews, men with erectile dysfunction had a higher risk of cardiovascular disease (relative risk 1.45), coronary heart disease (1.50), heart attack (1.55) and stroke (1.36).
The UAE expert panel on erectile dysfunction put it the same way: a cardiovascular event can follow within two to three years of the diagnosis, so erectile dysfunction is treated as an indicator of other conditions rather than as a problem on its own.
- Low cardiac risk: treatment can proceed
- Intermediate risk: an exercise stress test first. A positive test means further cardiac assessment before treatment
- High risk: cardiology review before any treatment for erectile dysfunction is started
The cardiovascular risk is then managed in its own right, not just cleared as a hurdle. How that assessment is done.
Is a scan needed?
Usually not. Penile ultrasound is used where the cause is unclear, where there has been trauma or priapism, in Peyronie disease, or where medication has failed.
Overnight erection testing in a sleep laboratory is no longer routine. Home monitoring devices can quantify erections during sleep where that question genuinely matters.
ED consultations in Dubai and the UAE
Why does this get assessed properly here?
Because the shortcut is so easy to take. In a survey of 1,008 men in the region, 37.5 percent had used a PDE5 inhibitor, only 38.1 percent of those users actually had erectile dysfunction, and 84.1 percent had bought the drug without a prescription (reported in the UAE expert panel review, 2025).
Every one of those men skipped the nitrate question and the cardiac assessment. That is the specific risk this appointment removes.
Does the local risk profile change the workup?
It raises the yield of the blood tests. The national survey of the Ministry of Health and Prevention found raised blood glucose in 12.5 percent of adults, and in a Dubai series of men with premature coronary artery disease the average age was 42.
So the glucose and lipid results here are not a formality attached to a sexual complaint. They are often the more consequential half of the appointment.
Is the consultation confidential?
Yes. It is an ordinary medical consultation and is documented like any other, with the usual confidentiality of the doctor-patient relationship.
The UAE expert panel identified reluctance to seek treatment as one of the main obstacles here, and noted a strong social stigma around psychological care in particular. What the panel found.
Before the consultation: the 1-minute erection check with the IIEF-5 score. The tablets chosen most often: sildenafil (Viagra) and tadalafil (Cialis).
Your first consultation
Sit down with Dr. Felix, say what you want to know and leave with a clear plan. One physician, from the first question to the follow-up.
Who Is a Good Candidate?
- Erections have become unreliable and you want the cause identified rather than just a prescription
- You have been given tablets elsewhere without any assessment
- You have diabetes, high blood pressure or high cholesterol, or you smoke
- You take nitrates, or are not sure whether one of your medicines counts as one
- You want the cardiovascular side taken seriously as well as the sexual side
- Chest discomfort or breathlessness on exertion, which needs cardiac assessment before any treatment
- You take nitrates in any form, regularly or occasionally, which rules out the standard tablets entirely
- Visual field changes with headaches, which can indicate a pituitary cause
What Happens During the Consultation
-
1
The sexual history
Onset, morning erections, whether the erection is lost after penetration, whether desire has changed, and whether it happens in every situation. Ejaculatory problems and any penile curvature are asked about at the same time.
-
2
Medication, risk factors and the relationship
Antidepressants and antihypertensives are common contributors. Smoking, weight, diabetes, blood pressure and lipids are recorded. Interpersonal conflict is asked about, because it is common and rarely volunteered.
-
3
Examination and bloods
Pulses, penile examination, testicular size, breast tissue, hair pattern and visual fields. Bloods cover glucose or HbA1c, blood count, liver and kidney function, thyroid, lipids and testosterone.
-
4
Cardiac risk graded, then the plan
Low, intermediate or high. Intermediate means an exercise test first, high means cardiology review first. Only then is treatment discussed, with a baseline score recorded so improvement can be measured.
Program Structure & Follow-Up
What happens after the consultation
Results are explained with what each one means, including the cardiovascular findings, which usually matter more in the long run than the sexual ones.
The first review
- Whether the treatment is working, measured against the baseline score rather than an impression
- Whether it was taken correctly, since proper instruction rescues about 25 to 30 percent of men who appeared not to respond
- Side effects, and whether a different drug in the same class would suit better
What counts as a meaningful improvement
A defined change on a validated score, the International Index of Erectile Function: two points for mild, five for moderate and seven for severe erectile dysfunction. That is why a baseline is recorded before anything is started.
Alongside the sexual treatment
Three findings get treated in their own right, whatever happens with the erections.
| Finding | What follows |
|---|---|
| Cardiovascular risk | Managed as cardiovascular risk, because erectile dysfunction often arrives before the cardiac diagnosis |
| Newly found diabetes | Treated as diabetes, which is the more consequential diagnosis of the two |
| Low testosterone | Confirmed on a repeat morning sample with LH and prolactin, then treated with its own monitoring schedule |
If the first treatment does not work
Second line options exist and are discussed rather than the case being closed. What comes after the tablets.
Benefits, Limits & Safety
What the consultation delivers
A cause rather than a guess, a cardiac risk category, a baseline score, and a treatment that is safe to take given everything else you are on.
It also delivers a cardiovascular assessment that many men would not otherwise have had, at an age where it is worth having.
What the consultation cannot do
- It cannot make a treatment safe if you take nitrates. That is an absolute contraindication, not a relative one
- It cannot fix a relationship problem, and where that is the driver it will be named rather than prescribed around
- It cannot short circuit the cardiac assessment where the risk is intermediate or high
One partner’s difficulty measurably affects the other’s, which is why the partner is part of the plan wherever there is one. Why the partner is included.
The honest note about testosterone
Testosterone is measured in every man presenting with erectile dysfunction, as the urology guidelines recommend. But it is the cause less often than expected, and testosterone on its own improves desire more reliably than it improves erections.
Measuring it in everyone rather than only in men with obvious signs is deliberate, because restricting the test to men with low desire or physical signs of deficiency misses a substantial share of the cases that are found. Where testosterone genuinely helps.
What is not offered
Prescriptions without assessment, treatment before the cardiac question is settled, and shockwave or platelet based therapies marketed as regenerative, which do not have the evidence base to justify them.
A cause, not a guess
History and examination identify the cause in about 95 per cent of cases, and the tests confirm it rather than starting the search.
A baseline before treatment
A validated score recorded first, so improvement is a defined change rather than an impression. Two points for mild, five for moderate, seven for severe.
Absolute stop
Nitrates in any form, regular or occasional. High cardiac risk needs cardiology review, and intermediate risk needs an exercise test, before treatment starts.
Cost & Program Investment
The consultation and the blood panel are quoted before anything is ordered. The panel is a standard one rather than a specialist hormone screen. Where cardiac risk means an exercise test or cardiology review is needed first, that is arranged and quoted rather than skipped to reach a prescription faster. Medication itself is an ordinary prescription bought at pharmacy prices.
Frequently Asked Questions
Not before the heart question is settled. PDE5 inhibitors cannot be combined with nitrates in any form, sexual activity is physical exertion, and erectile dysfunction is itself an early warning sign of cardiovascular disease. In a regional survey, 84.1 percent of men using these drugs had bought them without a prescription, which means none of that was checked.
Long enough for the history, because the history identifies the cause in about 95 percent of cases. The tests follow the history rather than replacing it.
Fasting glucose or HbA1c, a full blood count, liver and kidney function, thyroid function, a lipid profile and total testosterone. If testosterone is low it is repeated on a second morning sample with LH and prolactin before any decision.
Because the two are the same problem seen from different ends. In an umbrella review of five meta-analyses and two systematic reviews, men with erectile dysfunction had a 45 percent higher relative risk of cardiovascular disease and a 55 percent higher relative risk of heart attack, and a cardiovascular event can follow within two to three years of the diagnosis.
Usually not. Penile ultrasound is reserved for an unclear cause, previous trauma or priapism, Peyronie disease, or failure of medication. Overnight testing in a sleep laboratory is no longer routine.
First it gets checked whether it was taken correctly, because proper instruction rescues about 25 to 30 percent of apparent non-responders. If it genuinely has not worked, the dose is adjusted, then a different drug in the same class is tried, and after that the second line options are discussed.
Yes. It is an ordinary medical consultation, documented like any other, with the usual confidentiality of the doctor-patient relationship.
It raises the likelihood substantially. In men with diabetes attending a community clinic the prevalence of erectile dysfunction rose from 6 percent at ages 20 to 24 to 52 percent at ages 55 to 59, and severity tracked the duration of the diabetes, glucose control and the presence of small vessel disease.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Erectile dysfunction: expert panel recommendations for evaluation and management in the United Arab EmiratesJournal of Multidisciplinary Healthcare (PubMed abstract) · Haddad A et al., 2025, panel of ten specialists convened in Dubai
- Erectile dysfunction: expert panel recommendations for the UAE, full textJournal of Multidisciplinary Healthcare, open access · Full text of the 2025 UAE expert panel recommendations
- Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analysesBJU International (PubMed abstract) · 2021, five meta-analyses and two systematic reviews
- Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJournal of Urology (PubMed abstract) · Feldman HA et al., 1994, 1,290 men aged 40 to 70
- EAU guidelines on sexual and reproductive healthEuropean Association of Urology · The guideline the UAE expert panel used as its base
- MoHAP releases National Health and Nutrition Survey 2024-2025UAE Ministry of Health and Prevention, via Emirates News Agency (WAM) · 6 January 2026
- Major determinants of early-onset coronary artery disease: a descriptive study from a tertiary care hospital in DubaiCureus (PubMed abstract) · 2025, 110 patients treated in Dubai between 2018 and 2022
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.